Non-steroidal anti-inflammatory drugs (NSAIDS) lower the risk of developing Alzheimer’s disease, claim researchers in this week’s BMJ.
The authors identified 15 studies published between 1996 and October 2002 that examined the role of NSAID use in preventing Alzheimer’’s disease. They carried out three separate analyses to quantify the risk of Alzheimer’’s disease in NSAID users and in aspirin users and to determine any influence on duration of use.
Their results show that NSAIDS offer some protection against the development of Alzheimer’’s disease and that the benefits may be greater the longer NSAIDs are used.
They also suggest that aspirin has a protective effect, but this result was not significant, probably because of the small number of studies that specifically evaluated the effects of aspirin.
However, the appropriate dose, duration, and the ratios of risk to benefit are still unclear, they conclude.
Emma Dickinson | Source: alphagalileo
Further information: www.bmj.com
More articles from Health and Medicine:
Immune system activated in schizophrenia
20.11.2009 | Karolinska Institutet
New research helps explain why bird flu has not caused a pandemic
20.11.2009 | Imperial College London
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News